These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 8978697

  • 1. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.
    Krappmann D, Wulczyn FG, Scheidereit C.
    EMBO J; 1996 Dec 02; 15(23):6716-26. PubMed ID: 8978697
    [Abstract] [Full Text] [Related]

  • 2. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo.
    Rodriguez MS, Wright J, Thompson J, Thomas D, Baleux F, Virelizier JL, Hay RT, Arenzana-Seisdedos F.
    Oncogene; 1996 Jun 06; 12(11):2425-35. PubMed ID: 8649784
    [Abstract] [Full Text] [Related]

  • 3. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo.
    Roff M, Thompson J, Rodriguez MS, Jacque JM, Baleux F, Arenzana-Seisdedos F, Hay RT.
    J Biol Chem; 1996 Mar 29; 271(13):7844-50. PubMed ID: 8631829
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
    Karin M, Ben-Neriah Y.
    Annu Rev Immunol; 2000 Mar 29; 18():621-63. PubMed ID: 10837071
    [Abstract] [Full Text] [Related]

  • 7. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis.
    Sharipo A, Imreh M, Leonchiks A, Imreh S, Masucci MG.
    Nat Med; 1998 Aug 29; 4(8):939-44. PubMed ID: 9701247
    [Abstract] [Full Text] [Related]

  • 8. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
    Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, Maniatis T.
    Genes Dev; 1995 Jul 01; 9(13):1586-97. PubMed ID: 7628694
    [Abstract] [Full Text] [Related]

  • 9. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
    Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben-Neriah Y.
    Proc Natl Acad Sci U S A; 1995 Nov 07; 92(23):10599-603. PubMed ID: 7479848
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis.
    Milligan SA, Owens MW, Grisham MB.
    Arch Biochem Biophys; 1996 Nov 15; 335(2):388-95. PubMed ID: 8914937
    [Abstract] [Full Text] [Related]

  • 11. Inducible NF-kappaB activation is permitted by simultaneous degradation of nuclear IkappaBalpha.
    Renard P, Percherancier Y, Kroll M, Thomas D, Virelizier JL, Arenzana-Seisdedos F, Bachelerie F.
    J Biol Chem; 2000 May 19; 275(20):15193-9. PubMed ID: 10809754
    [Abstract] [Full Text] [Related]

  • 12. Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation product.
    Li CC, Dai RM, Longo DL.
    Biochem Biophys Res Commun; 1995 Oct 04; 215(1):292-301. PubMed ID: 7575604
    [Abstract] [Full Text] [Related]

  • 13. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity.
    Yin L, Laevsky G, Giardina C.
    J Biol Chem; 2001 Nov 30; 276(48):44641-6. PubMed ID: 11572859
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132.
    Fiedler MA, Wernke-Dollries K, Stark JM.
    Am J Respir Cell Mol Biol; 1998 Aug 30; 19(2):259-68. PubMed ID: 9698598
    [Abstract] [Full Text] [Related]

  • 15. Amino acid analogs activate NF-kappaB through redox-dependent IkappaB-alpha degradation by the proteasome without apparent IkappaB-alpha phosphorylation. Consequence on HIV-1 long terminal repeat activation.
    Kretz-Remy C, Bates EE, Arrigo AP.
    J Biol Chem; 1998 Feb 06; 273(6):3180-91. PubMed ID: 9452429
    [Abstract] [Full Text] [Related]

  • 16. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.
    Bour S, Perrin C, Akari H, Strebel K.
    J Biol Chem; 2001 May 11; 276(19):15920-8. PubMed ID: 11278695
    [Abstract] [Full Text] [Related]

  • 17. Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production.
    Uehara T, Matsuno J, Kaneko M, Nishiya T, Fujimuro M, Yokosawa H, Nomura Y.
    J Biol Chem; 1999 May 28; 274(22):15875-82. PubMed ID: 10336492
    [Abstract] [Full Text] [Related]

  • 18. NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events.
    Huang TT, Wuerzberger-Davis SM, Seufzer BJ, Shumway SD, Kurama T, Boothman DA, Miyamoto S.
    J Biol Chem; 2000 Mar 31; 275(13):9501-9. PubMed ID: 10734098
    [Abstract] [Full Text] [Related]

  • 19. A caspase-3-like protease is involved in NF-kappaB activation induced by stimulation of N-methyl-D-aspartate receptors in rat striatum.
    Qin Z, Wang Y, Chasea TN.
    Brain Res Mol Brain Res; 2000 Sep 15; 80(2):111-22. PubMed ID: 11038244
    [Abstract] [Full Text] [Related]

  • 20. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
    Palombella VJ, Rando OJ, Goldberg AL, Maniatis T.
    Cell; 1994 Sep 09; 78(5):773-85. PubMed ID: 8087845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.